Bill > HB1416

This bill introduces new regulations for group insurance plans in Oklahoma regarding the coverage of non-opioid pain treatments. The bill defines key terms, including "non-opioid treatment" as a drug that provides pain relief without acting on opioid receptors and is uniquely rated by the Food and Drug Administration. It requires insurers offering group insurance plans to ensure that non-opioid drugs are not disadvantaged or discouraged in coverage compared to opioid or narcotic pain medications when establishing a preferred drug list (PDL). The legislation does not prevent insurers from preferring specific opioid or non-opioid medications over others within their respective categories. The bill applies to non-opioid treatments that have been reviewed and approved for coverage by group insurance plans and covers drugs provided under contracts between insurers and pharmacy benefits managers. By mandating fair consideration of non-opioid treatments, the bill aims to provide more balanced pain management options for state employees. The bill is set to become effective on November 1, 2025, giving insurers time to adjust their drug lists and coverage policies accordingly.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=hb1416&Session=2600